The TGM2 knockdown group (shTgm2) exhibited significant increases in the duration of epileptiform discharges (p < 0.05) and frequency of SLE episodes when compared with the control group (Con‐shTgm2) (p < 0.01) (Figure 2P,Q). Here, TGM2 is linked to systemic lupus erythematosus.